Consumption of fruits, vegetables and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. by Zamora-Ros, Raul et al.
1 
 
Consumption of fruits, vegetables, and fruit juices and 
differentiated thyroid carcinoma risk in the European 
Prospective Investigation into Cancer and Nutrition (EPIC) 
study 
Raul Zamora-Ros1,*, Virginie Béraud1,*, Silvia Franceschi2, Valerie Cayssials1, 
Konstantinos K. Tsilidis3,4, Marie-Christine Boutron-Ruault5,6, Elisabete 
Weiderpass7,8,9,10, Kim Overvad11, Anne Tjønneland12, Anne Kirstine Eriksen12, 
Fabrice Bonnet5,6,13, Aurélie Affret5,6, Verena Katzke14, Tilman Kühn14, Heiner 
Boeing15, Antonia Trichopoulou16,17, Elisavet Valanou16, Anna Karakatsani16,18, 
Giovanna Masala19, Sara Grioni20, Maria Santucci de Magistris21, Rosario 
Tumino22, Fulvio Ricceri23,24, Guri Skeie7, Christine L Parr25, Susana Merino26, 
Elena Salamanca-Fernández27,28, Maria-Dolores Chirlaque28,29,30, Eva 
Ardanaz28,31,32, Pilar Amiano28,33, Martin Almquist34,35, Isabel Drake36, Joakim 
Hennings37, Maria Sandström38, H. Bas Bueno-de-Mesquita4,39, Petra H. 
Peeters4,40, Kay-Thee Khaw41, Nicholas J. Wareham42, Julie A. Schmidt43, Aurora 
Perez-Cornago43, Dagfinn Aune4,44,45, Elio Riboli4, Nadia Slimani2, Augustin 
Scalbert2, Isabelle Romieu2, Antonio Agudo1, Sabina Rinaldi2 
Author affiliations 
1Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan 
Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, 
Spain. 
2International Agency for Research on Cancer (IARC), Lyon, France. 
3Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, 
Ioannina, Greece 
4School of Public Health, Imperial College London, London, UK 




6Institut Gustave Roussy, F-94805, Villejuif, France. 
7Department of Community Medicine, Faculty of Health Sciences, UiT, The Artic 
University of Tromsø, Tromsø, Norway. 
8Department of Research, Cancer Registry of Norway, Institute of Population-Based 
Cancer Research, Oslo, Norway. 
9Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
Stockholm, Sweden. 
10Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland. 
11Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, 
Denmark. 
12Danish Cancer Society Research Center, Copenhagen, Denmark. 
13CHU Rennes, Rennes 1 University, Rennes, France 
14Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, 
Germany. 
15Department of Epidemiology, German Institute of Human Nutrition Potsdam-
Rehbruecke, Nuthetal, Germany. 
16Hellenic Health Foundation, Athens, Greece 
17WHO Collaborating Center for Nutrition and Health, Unit of Nutritional 
Epidemiology and Nutrition in Public Health, Dept. of Hygiene, Epidemiology and 
Medical Statistics, School of Medicine, National and Kapodistrian University of 
Athens, Greece 
182nd Pulmonary Medicine Department, School of Medicine, National and Kapodistrian 
University of Athens, “ATTIKON” University Hospital, Haidari, Greece 
3 
 
19Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and 
Prevention Institute – ISPO, Florence, Italy 
20Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 
Milan, Italy. 
21Department of Clinical and Experimental Medicine, Federico II University, Naples, 
Italy. 
22Cancer Registry and Histopathology Unit, "Civic M.P. Arezzo" Hospital, ASP 
Ragusa, Italy. 
23Department of Clinical and Biological Sciences, University of Turin, Turin, Italy 
24Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco (TO), Italy 
25Domain of Mental and Physical Health, Norwegian Institute of Public Health, Oslo, 
Norway 
26Public Health Directorate, Asturias, Spain. 
27Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria 
ibs.Granada. Hospitales Universitarios de Granada/Universidad de Granada, Granada, 
Spain. 
28CIBER de Epidemiología y Salud Pública (CIBERESP), Spain. 
29Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia, 
Spain 
30Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain 
31Navarra Public Health Institute, Pamplona, Spain 
32Navarra Institute for Health Research (IdiSNA) Pamplona, Spain 
4 
 
33Public Health Division of Gipuzkoa, Regional Government of the Basque Country, 
Spain 
34Department of Surgery, University Hospital Lund, Lund, Sweden 
35Malmö Diet and Cancer Study, University Hospital Malmö, Malmö, Sweden 
36Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden 
37Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden 
38Department for Radiation Sciences, Umeå University, Umeå, Sweden 
39Department for Determinants of Chronic Diseases (DCD), National Institute for 
Public Health and the Environment (RIVM), Bilthoven, The Netherlands 
40Department of Epidemiology, Julius Center for Health Sciences and Primary Care, 
University Medical Center Utrecht, Utrecht, The Netherlands 
41Department of Public Health and Primary Care, University of Cambridge, UK 
42MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, 
Cambridge, UK 
43Cancer Epidemiology Unit, University of Oxford, UK 
44Department of Public Health and General Practice, Norwegian University of Science 
and Technology, Trondheim, Norway. 
45Bjørknes University College, Oslo, Norway. 
 
*Both authors equally contributed to this research. 
 
The entire manuscript is 4,181 words (including abstract (229 words), text (3,952 
words), 53 references, 3 tables, 3 supplementary table). 
5 
 
Running Title: Fruits, vegetables, and fruit juices and thyroid cancer in EPIC 
Corresponding author: Raul Zamora-Ros, Unit of Nutrition and Cancer, Catalan 
Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Av 
Gran Via 199-203, 08908 L’Hospitalet de Llobregat, Spain. Phone: +34 932067401. 
Fax: +34 932607787.  
E-mail: rzamora@iconcologia.net 
Key words: Thyroid cancer, Fruits, Vegetables, Fruit juices, Intake, EPIC 
Abbreviations: 24-HDR: 24-h dietary recall; BMI: Body Mass Index; CI: Confidence 
Interval; EPIC: European Prospective Investigation into Cancer and Nutrition; F&V: 
Fruits and Vegetables; HR: Hazard Ratio; IARC: International Agency for Research on 
Cancer; NOS: Not Otherwise Specified; TC: Thyroid cancer  





NOVELTY AND IMPACT OF THE WORK: 
This large prospective cohort does not support any association between the consumption 
of vegetable, fruit and any individual type of vegetable or fruit and differentiated 
thyroid carcinoma risk, overall and by histologic type (papillary and follicular tumours). 
However, a positive trend with fruit juice intake was observed, possibly related to its 




Fruit and vegetable (F&V) intake is considered as probably protective against overall cancer 2 
risk, but results in previous studies are not consistent for thyroid cancer (TC). The purpose of 3 
this study is to examine the association between the consumption of fruits, vegetables, fruit 4 
juices and differentiated thyroid cancer risk within the European Prospective Investigation 5 
into Cancer and Nutrition (EPIC) study. The EPIC study is a cohort including over half a 6 
million participants, recruited between 1991 and 2000. During a mean follow-up of 14 years, 7 
748 incident first primary differentiated TC cases were identified. F&V and fruit juice intakes 8 
were assessed through validated country-specific dietary questionnaires. Hazard ratios (HRs) 9 
and 95% confidence intervals (CIs) were estimated using Cox regression models adjusted for 10 
potential confounding factors. Comparing the highest vs. lowest quartile of intake, 11 
differentiated TC risk was not associated with intakes of total F&V (HR: 0.89; 95% CI: 0.68-12 
1.15; p-trend=0.44), vegetables (HR: 0.89; 95% CI: 0.69-1.14; p-trend=0.56), or fruit (HR: 13 
1.00; 95% CI: 0.79-1.26; p-trend=0.64). No significant association was observed with any 14 
individual type of vegetable or fruit. However, there was a positive borderline trend with fruit 15 
juice intake (HR: 1.23; 95% CI: 0.98-1.53; p-trend=0.06). This study did not find any 16 
significant association between F&V intakes and differentiated TC risk; however a positive 17 





The consumption of fruits and vegetables (F&V) has been consistently associated with a 21 
reduced risk of many cancers in case-control studies, but these associations become weak or 22 
even null in cohorts.1-3 In 2003 the World Health Organization (WHO)4 and in 2007 the 23 
International Agency for Research on Cancer (IARC)5 concluded that there was convincing 24 
evidence that F&V lower the risk of cardiovascular diseases and probable evidence for lower 25 
respiratory and digestive cancer risks. Therefore, they recommended an intake of 400–500 26 
g/day, the well-known campaign of 5 a day (including vegetables, fruits and also juices, 27 
although juices are usually recommended ≤1 portion per day by several national nutrition 28 
health programmes, e.g. in the UK, France, Norway, etc.). However, little is known about its 29 
association with thyroid cancer (TC) risk, particularly in prospective studies. TC is the most 30 
common endocrine cancer (1-1.5% of all new cancers diagnosed each year) worldwide6 and 31 
the incidence has been constantly increasing over the last three decades,7-10 mainly explained 32 
by over-diagnosis.11  33 
In 2014, a meta-analysis of 19 case-control studies on dietary factors and TC risk found a 34 
weak inverse association with the intake of vegetables and no association with the intake of 35 
fruits.12 Cruciferous vegetables have been studied more closely due to their content in 36 
goitrogenic substances,13 which have tumour promoting effects upon rats’ thyroid.14,15 Two 37 
recent meta-analyses of retrospective studies found either no association or a positive 38 
association between the intake of cruciferous vegetables and differentiated TC risk.12,16 For 39 
juices, a positive association was suggested between citrus fruit juice intake and TC risk.17 40 
The aim of the present study was to prospectively evaluate the association between the 41 
consumption of vegetables, fruits, fruit juices and their subtypes and differentiated TC risk in 42 
the European Prospective Investigation into Cancer and Nutrition (EPIC) study, a large cohort 43 




MATERIAL AND METHODS 46 
Study population 47 
EPIC is a multicentre prospective cohort study principally designed to investigate the 48 
relationships between diet and other environmental factors and cancer risk. The study design 49 
has been explained in detail previously.19,20 In brief, EPIC enrolled more than half a million 50 
participants, 70% women, mostly aged between 35 and 70 years old from 23 centres in 10 51 
western European countries (Denmark, France, Germany, Greece, Italy, Norway, Sweden, 52 
Spain, the Netherlands, and the United Kingdom) during the period 1991-2000. All 53 
participants gave their written informed consent, and the Internal Review Boards of the IARC 54 
and all ethical committees from participating centres approved the project.  55 
Dietary assessment 56 
Validated country-specific dietary questionnaires were used to evaluate participants’ diets 57 
over the 12 months preceding recruitment.19 They were designed to collect the specificity of 58 
local dietary habits and provide optimal compliance. According to the centres, quantitative or 59 
semi-quantitative methods were applied. In Malmö-Sweden, a combination of a 7-day record 60 
and a semi-quantitative food frequency questionnaire was administered. Questionnaires were 61 
mainly self-reported except for Greece, Spain and two centres in Italy (Naples and Ragusa) 62 
where they were administered during a face-to-face interview. Lifestyle questionnaires about 63 
educational and socio-economic status, lifetime history of tobacco smoking and alcohol 64 
consumption, physical activity, menstrual and reproductive history and medical history were 65 
also collected at baseline.19   66 
The analysed food groups were vegetables (potatoes and legumes were not included), fresh 67 
fruits (excluding nuts, olives, and seeds), and total juices or fruit juices (including citrus fruit 68 
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juices, non-citrus fruit juices, vegetable juices and fruit nectars). Vegetable juices were rarely 69 
consumed (<2% of total juices) and this item was only recorded in the dietary questionnaires 70 
of 3 countries; for this reason we have simplified and used the term fruit juices instead of total 71 
juices. Total intake of F&V was calculated as the sum of fruits and vegetables, excluding fruit 72 
juices because of their large differences in nutritional composition compared to F&V.18 73 
Subgroups of vegetables and fruits were also considered: leafy vegetables, fruiting vegetables, 74 
root vegetables, cabbages, mushrooms, grain and pod vegetables, onion/garlic, sprouts/stalk 75 
vegetables, citrus fruits, hard fruits (apples and pears), berries (strawberries, grapes, 76 
blueberries), stone fruits (peach, nectarine, apricot, plum, cherry), banana, and other fruits 77 
(fig, kiwi, melon, watermelon, pineapple). Details about the composition of the subgroups are 78 
given elsewhere.18 79 
Follow-up and case ascertainment  80 
Except for Germany and Greece, all information on vital status came from national or 81 
regional mortality registries. In Germany and Greece, those data were continuously collected 82 
through an active follow-up. Cancer incident cases were identified through regional/national 83 
cancer registries, except for German, Greek, and French centres. For those, different methods 84 
were used, including health insurance records, contacts with cancer pathology registries, and 85 
active follow-up through study participants or relatives. Complete follow-up censoring dates 86 
ranged from December 2010 to December 2014, depending on the study centre.19 Cancer 87 
cases were defined as subjects with a first primary TC (code C73 according to the 88 
International Classification of Diseases, 10th Revision) during follow-up. Differentiated TC 89 
comprises papillary and follicular tumours. 90 
Of the 857 TC cases, anaplastic (n=9), medullary (n=37), lymphoma (n=1) forms and “other 91 
morphologies” (n=5) were excluded. Moreover, 29,332 participants (including 45 92 
differentiated TC cases) were excluded from the initial database because of missing or null 93 
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follow-time or having a prevalent cancer other than non-melanoma skin cancer. Further 1,277 94 
and 14,555 participants (including 12 differentiated TC cases) were also excluded because 95 
their lifestyle and dietary data were not complete or coherent (they were in the top or the 96 
bottom 1% of the distribution of the total energy intake to energy requirement ratio), 97 
respectively. Finally, 748 first primary incident differentiated TC cases were considered: 601 98 
papillary TCs, 109 follicular TCs, and 38 not otherwise specified (NOS) TCs, most likely 99 
papillary TCs. A total of 142,232 men and 333,876 women were included in the present 100 
study. 101 
Statistical analysis 102 
Cox proportional hazard models were used to estimate hazard ratios (HR) and 95% 103 
confidence intervals (CI). Intakes of vegetables, fruits, and fruit juices were stated in grams 104 
per day. They were analysed as continuous variables (increments of 100 g/d for groups and 50 105 
g/d or 10 g/d for subgroups), and as categorical variables using EPIC-wide quartiles (quartile 106 
1 as reference) or EPIC-specific quartiles by sex, BMI categories, and physical activity status 107 
for subgroup analyses. Tests for linear trend were performed by attributing the median of each 108 
quartile as a score. Age was the primary time variable in all models. Entry time was age at 109 
recruitment and exit time was age at diagnosis of differentiated TC, death, or censoring date 110 
(loss of follow-up, end of follow-up), whichever occurred first. Two sets of models were used 111 
without (model A) and with (model B) adjustment for total energy intake. Model A1 was 112 
stratified by sex, age at recruitment (1-year interval) and centre. Model A2 was model A1 113 
additionally adjusted for non-dietary variables: BMI, smoking status (never, former, current 114 
smoker, and unknown), education (primary, secondary, and unknown), physical activity 115 
(inactive, active, and unknown according to the Cambridge Physical Activity Index),21 type of 116 
menopause (pre-, peri-, post-, and surgical menopause), use of oral contraceptives (yes, no, 117 
and unknown), and fertility problems (yes, no, and unknown), since these reproductive factors 118 
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were TC risk factors in our previous study.22 Model B1 was stratified by sex, age recruitment 119 
(1-year interval) and centre, and adjusted for total energy intake (kcal/day). Model B2 was 120 
model B1 additionally adjusted for non-dietary variables (as model A2) and dietary variables: 121 
total alcohol (g/day) intake. We also created an additional model (model B3) for the main 122 
exposure groups, which was model B2 mutually adjusted, when appropriate, for vegetables, 123 
fruits, and fruit juices, accordingly. The interpretation of models without total energy intake is 124 
focused on the impact of the effect of the absolute amount of compounds of F&V and fruit 125 
juices (e.g. vitamins, polyphenols, and contaminants). Whereas in the case of the models with 126 
total energy intake adjustment, the relevance is the relative amount compare to other 127 
compounds, like in a substitution model. Tests and graphs based on Schoenfeld residuals were 128 
used to assess proportional hazards assumptions, which were satisfied. Separate analyses were 129 
performed for TC subtypes: follicular and papillary tumours. Heterogeneity of risk between 130 
TC subtypes was assessed with the Wald test. Possible interactions with sex, smoking status, 131 
BMI (BMI<25 vs. BMI≥25), alcohol intake at recruitment (≤24 g/d vs. >24 g/d), and physical 132 
activity (inactive, active) were tested by including an interaction term in the multi-adjusted 133 
models. The Wald test was used to evaluate the heterogeneity of risk between BMI and 134 
physical activity categories. Sensitivity tests were performed i) excluding female participants 135 
from France, since they contributed to 37.2% of all differentiated TC cases among all female 136 
participants, and over-diagnosis in France could be relatively high;11 (ii) excluding 137 
participants who had diabetes or unknown diabetes status at baseline, because diabetes is a 138 
potential risk factor of TC and iii) excluding cases with a follow-up period below two years, 139 
since they could have changed their diets in the pre-diagnostic period. For all analyses, p-140 
values <0.05 were considered as statistically significant and p-values >0.05 and <0.1 as 141 
borderline statistically significant. To account for multiple testing for the subgroups of F&V, 142 
Bonferroni correction was used and then results were considered statistically significant if 143 
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P<0.05/23 (number of tests for the intakes of total F&V, vegetables, fruits, fruit juices and all 144 
subgroups)=0.002. All statistical analyses were performed with the R 3.3.1 software (R 145 
Foundation for Statistical Computing, Vienna, Austria). 146 
Calibration of dietary data 147 
A second dietary measurement was taken from an 8% random sample of the cohort (36,994 148 
participants) using a detailed computerized 24-h dietary recall (24-HDR) method23 to 149 
calibrate dietary measurements of vegetable, fruit, and fruit juice intake across countries and 150 
to correct for systematic overestimation or underestimation of dietary intakes.24 The 24-HDR 151 
values of these participants were regressed on the main dietary questionnaire values for 152 
vegetables, fruits, and fruit juices with adjustment for age at recruitment, centre, and total 153 
energy intake, and weighting by day of the week and season of the year during which the 24-154 
HDR was collected. Zero consumption values in the main dietary questionnaires were 155 
excluded in the regression calibration models, and a zero was directly imputed as a corrected 156 
value. Country and sex-specific calibration models were used to obtain individual predicted 157 
values of dietary exposure for all participants. Cox regression models were then run using the 158 
predicted (calibrated) values for each individual on a continuous scale. The standard error of 159 
the calibrated coefficient was estimated with bootstrap sampling in the calibration and disease 160 
models and repeated 300 times.24 161 
RESULTS 162 
The median (percentile 25th and 75th) intakes of total F&V, vegetables, fruits, and fruit juices 163 
were 391 g/d (250-576 g/d), 175 g/d (110-276 g/d), 194 g/d (106-314 g/d), and 20 g/d (1-94 164 
g/d), respectively. A great heterogeneity of F&V consumption in both men and women 165 
among EPIC countries was observed with higher F&V intakes in Southern than in Northern 166 
EPIC countries(Table 1). Differentiated TC incidence was higher among women (89% of 167 
cases) and the most common subtype was papillary (80.3%), followed by follicular (14.6%), 168 
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and NOS tumours (5.1%) (Table 1). The analysis of baseline characteristics according to 169 
quartiles of total intake of F&V showed that participants in the highest quartile were more 170 
likely to be older women, less educated, and less physically active, and to have higher total 171 
energy intake and lower tobacco and alcohol consumptions. Women in the highest quartile of 172 
F&V tended to be postmenopausal or to have undergone surgical menopause, to have more 173 
infertility problems, and to take less oral contraceptives at the baseline (Supplementary 174 
Table 1). 175 
Four multivariable Cox models with different levels of adjustment (with and without total 176 
energy intake) were performed, showing similar results (difference below 10%) (Table 2 and 177 
Supplementary table 2). In the fully adjusted model (model B2), no association was 178 
observed between total intake of F&V and total differentiated TC risk for the highest vs. 179 
lowest quartile (HR: 0.89; 95% CI: 0.68-1.15; p-trend=0.44). No association was found with 180 
the intake of vegetables (HR: 0.89; 95% CI: 0.69-1.14; p-trend=0.56), or fruits (HR: 1.00; 181 
95% CI: 0.79-1.26; p-trend=0.64). A borderline positive trend between fruit juice intake and 182 
total differentiated TC risk was detected (HR: 1.23; 95% CI: 0.98-1.53; p-trend=0.06). After 183 
calibration, results were unchanged. In separate analyses by TC type, null results were 184 
observed between all exposures and either papillary or follicular TC risk (Table 2). A further 185 
model (model B3) was also estimated mutually adjusting for the intake of fruits, vegetables or 186 
fruit juices when appropriate and results were practically identical to those in model B2 187 
(Supplementary table 2). Sensitivity tests, excluding French participants, subject with diabetes 188 
at baseline, and cases with a follow-up below two years, showed results almost identical to 189 
those in the entire cohort (data not shown). 190 
No association between any subgroups of F&V intake and total differentiated TC risk was 191 
found (Table 3). Associations with papillary and follicular TC risk were also evaluated. For 192 
every 10g/day of sprouts/stalk vegetables, the risk of follicular TC was significantly lowered 193 
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for the observed data (HR: 0.72; 95% CI: 0.56-0.94; p-value=0.015) and for the calibrated 194 
data (HR: 0.56; 95% CI: 0.34-0.91%; p-value=0.020), but not for papillary TC risk. After 195 
applying the Bonferroni correction (p<0.002), the inverse association was no longer 196 
statistically significant. No associations were observed for any of the other subgroups of F&V 197 
with either papillary or follicular TC risk.  198 
No interactions were observed between total intake of F&V and any of the tested potential 199 
confounding factors: sex (P for interaction=0.84), smoking status (P for interaction=0.58), 200 
BMI (P for interaction=0.37), alcohol (P for interaction=0.54), and physical activity (P for 201 
interaction=0.41). Although no heterogeneity was observed between sexes, separate analyses 202 
by sex were performed because of the large proportion of women with TC. The study of the 203 
association between total intake of F&V and TC risk showed similar results from the previous 204 
analyses for both women (HR: 0.88; 95% CI: 0.68-1.15; p-trend=0.34) and men (HR: 0.95; 205 
95% CI: 0.42-2.12; p-trend=0.85) (data not tabulated). A statistically significant interaction 206 
between fruit juice intake and BMI (P for interaction=0.03) and borderline significant with 207 
physical activity (P for interaction=0.08) was detected. The highest quartile of fruit juice 208 
consumption was positively associated with TC risk among inactive participants (HR: 1.31; 209 
95% CI: 0.99-1.72; p-trend=0.05) but not among active subjects (HR: 1.00; 95% CI: 0.70-210 
1.42; p-trend=0.99); and in participants with BMI<25 (HR: 1.43; 95% CI: 1.08-1.89; p-211 
trend=0.002), but not in those with BMI≥25 (HR: 1.06; 95% CI: 0.75-1.48; p-trend=0.99). 212 
Similar results were found for the analyses by TC subtypes, especially by BMI categories 213 
(Supplementary table 3).  214 
DISCUSSION 215 
In the present study, we prospectively evaluated the association between total F&V and fruit 216 
juice intakes and differentiated TC risk. We did not observe any association between total 217 
F&V intake and either all differentiated, papillary, or follicular TC risk. Similar null results 218 
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were also found in a Korean case-control study on mainly papillary TC cases (90%) among 219 
women.25 Furthermore in our study, no associations with the consumption of either fruits or 220 
vegetables were observed; whereas a borderline statistical positive trend with fruit juice intake 221 
was detected. 222 
A meta-analysis of 19 case-control studies12 and a pooled-analysis of 11 case-control studies26 223 
summarized the associations between vegetable intake and TC risk, showing a weak inverse 224 
association with the intake of total vegetables and vegetables excluding cruciferous 225 
vegetables. An American cohort study of 300,000 participants (the NIH-AARP diet and 226 
health study) showed an impact of adolescent (12-13 years old) and midlife diet (10 years 227 
before recruitment when respondents were 41–62 years of age) on TC risk, with a significant 228 
inverse association of vegetable intake among women.27 Although intakes of vegetables 229 
consumed by both Americans at midlife and our study population were comparable, we did 230 
not find any association between the intake of vegetables and the risk of differentiated TC 231 
either overall or by subtype.  232 
In the present cohort study, we observed no association between differentiated TC risk and 233 
the consumption of cruciferous vegetables. Similar results were observed in two meta-234 
analyses and one pooled-analysis.12,26,28 However, in the most recent meta-analysis, a positive 235 
association was pointed out, after excluding studies evaluating only one type of cruciferous 236 
vegetables and hospital-based case-control studies.16 The NIH-AARP diet and health study 237 
also showed a positive association with the intake of broccoli during midlife in men, however 238 
no other cruciferous vegetables were considered in the dietary questionnaire.27 Overall, no 239 
association between the intake of vegetables and cruciferous vegetables and TC was observed 240 
in the last 5-10 years before diagnosis (i.e. middle and late adulthood), although potential 241 
relationships in earlier life stages, such as adolescence and young adulthood, could not be 242 
ruled out according to the results from the NHI-AARP study. Those results suggest that a diet 243 
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rich in cruciferous vegetables during early adulthood could have an impact in the early 244 
development of TC, but not during the 5-10 years prior to TC diagnosis, which is the mean 245 
time of follow-up of TC cases in our study.  246 
Overall, no associations were found with vegetable subclasses with overall, papillary or 247 
follicular TC risk. Some previous studies suggested inverse associations with raw 248 
vegetables,25 green vegetables,29 carrots,29,30 green salad,30 raw tomatoes,31 turnips,32 249 
rutabagas,32 and cassava.33 However, these studies were relatively small (<400 TC cases) and 250 
had a retrospective design. Moreover these inverse associations have not been consistently 251 
observed in other similar studies and were not even suggested in our large cohort. In the 252 
analysis by TC type, there was an inverse association with sprouts/stalk vegetables but only 253 
for follicular TC risk (n=109 cases), although no longer after Bonferroni correction. In 254 
addition, sprouts/stalk vegetables (including asparagus, celery, fennel and leek) are a very 255 
heterogeneous group and are generally consumed in low amounts in Europe, and therefore the 256 
results could be due to chance.  257 
In the current study, total fruit intake, as well as intake of fruit subtypes was not associated 258 
with TC risk. Although less information is available on this field, our findings are in 259 
concordance with the results of previous studies, including the meta-analysis of 19 case-260 
control studies12 and the American cohort study considering adolescent and midlife periods.27 261 
Some studies showed a special interest in citrus fruits because of their high content in 262 
antioxidants (such as vitamin C and flavonoids). A pooled-analysis of four Italian-based case-263 
control studies showed an inverse association with TC risk.30 Both Greek and South Korean 264 
case-control studies reported inverse associations with the consumption of lemons31 and 265 
tangerines,25 respectively. However, in the present study, there was no association with citrus 266 
fruits intake, similarly to the NIH-AARP cohort where consumption of orange and tangelos 267 
was not associated with TC risk in any period.17 268 
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In the present study, a positive trend between the intake of fruit juices and TC risk was 269 
observed, especially in subjects with a BMI<25 or physically inactive. In the NIH-AARP 270 
cohort study, the consumption of orange and grapefruit juices was also associated with a 271 
higher risk of TC.17 In our study, fruit juices were mainly citrus juices (>61%), but most of 272 
them were commercial fruit juices and fruit nectars (62.3%) with a high sugar content. The 273 
contribution of fruit juices to total sugars varied from <2% in Mediterranean countries to 15% 274 
in Germany.34 In our study, we cannot differentiate between commercial fruit juice and fruit 275 
nectar (fruit juice with added sugars), and therefore we cannot evaluate the impact of the 276 
consumption of fruit juices with different amounts of sugar in the TC risk. Moreover, we 277 
cannot distinguish between fruit juices and vegetable juices in all participating countries, 278 
although vegetable juices are rarely consumed (only contributing to <2% of total juices in our 279 
study). Our results by BMI categories were in concordance with a recent study within EPIC, 280 
showing that the intake of sugar was positively associated with TC risk among people with a 281 
BMI <25.35 This finding could be partially due to a higher consumption of fruit juices in 282 
subjects with a BMI<25 (66.9 g/d) than with a BMI≥25 (60.4 g/d). However, the opposite 283 
results would be expected, since overweight is a major determinant of insulin resistance and 284 
hyperinsulinemia,36 which were associated with a higher prevalence of differentiated TC.37 285 
Furthermore, after calibration, no differences in the association between fruit juice intake and 286 
TC by BMI were observed. This could be due to a higher under-reporting of fruit juice intake 287 
among overweight people. Therefore, we need to be cautious in the interpretation of these 288 
sub-analyses. In the analyses by physical activity status, the intake of fruit juices was 289 
positively associated with TC risk among inactive participants. It has been reported that 290 
physical activity significantly improves glycaemia and sensitivity to insulin, which have been 291 
associated with a higher risk of TC.37,38 Moreover, physical activity modifies female hormone 292 
levels,39 which may have a weak influence on TC risk.22,40 293 
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On one hand, various components of F&V and fruit juices could exert a protective effect 294 
against TC. The intake of vitamins (in particular vitamin C and E, carotenoids), polyphenols 295 
and fibre has been related to a reduced risk of TC in some studies.41,42 Moreover, a deficiency 296 
in magnesium may be involved in the aetiology of some thyroid diseases.43 However the 297 
protective effects of F&V and fruit juices components are not consistent and several studies 298 
showed null results,17,35,44,45 or even positive associations [e.g., with beta-carotene,46 vitamin 299 
C47 and flavanones].17 300 
On the other hand, F&V and fruit juices can also contain traces of chemical pesticides. A high 301 
exposure to organophosphate insecticides was associated with a higher TC incidence among 302 
spouses of pesticide applicators.48 Vegetables are also good sources of nitrates, accounting for 303 
80% of their intake in Westernized diets.49 They are involved in the formation of N-nitroso 304 
compounds, which are known carcinogens.50 Indeed, nitrate intake has been positively 305 
associated with TC risk in two cohort studies.51,52 Cruciferous vegetables contain large 306 
amounts of glucosinolates, which are a nutritional source of thiocyanates and isothiocyanates. 307 
Those molecules can block the action of carcinogenic substances and suppress the expression 308 
of neoplasia in initiated cancer cells,53 but they also act as goitrogens,13 promoting thyroid 309 
tumour growth in rats.14,15  310 
Strengths of the EPIC study are its prospective design, its large number of cancer cases, and 311 
the wide range of F&V and fruit juice intake across participants from 10 European countries 312 
with standardized information on diet and lifestyle exposures. Several limitations have to be 313 
taken into account. Although EPIC is a large study, participants are not representative of the 314 
whole population in most of the countries because of the criteria of recruitment, and therefore 315 
the results are not totally generalizable to general population. The measurement error in the 316 
estimation of F&V and fruit juice intake by dietary questionnaires may have attenuated our 317 
findings, although the use of the calibrated F&V and fruit juice data, obtained from the 318 
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standardized 24-HDR, did not alter the results. As discussed above, we do not have data on 319 
fruit juices and fruit nectars separately. Dietary and lifestyle habits during the follow-up 320 
period are not available in EPIC, although diet is relatively stable in adult populations through 321 
the years.  322 
To conclude, in the present study, no association with differentiated TC risk was observed for 323 
the consumption of total F&V, vegetables, fruits, and their subgroups. This result might be 324 
explained by a counterbalance between pro- and anti-carcinogenic effects of their 325 
components. However, fruit juice intake was associated with an increased risk of 326 
differentiated TC, possibly due to the high sugar content. Our study supports having a diverse 327 
intake of F&V, but not consuming too much fruit juice, especially those rich in sugars. 328 
Further prospective studies are warranted to confirm these relationships between fruit juice 329 
intake and TC risk.  330 
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Supplementary table 1. Baseline characteristics of participants in the EPIC study 
according to quartiles of combined intake of vegetables and fruits 
Characteristics 
Vegetables and fruits (g/d) 
Q1  Q2 Q3 Q4 
Cutoffs (mg/d) <250 250-391 392-576 >576 
Sex, male (%) 42 29.6 23.3 24.6 
Mean age (SD, y) 50.3 (9.7) 51.2 (9.8) 51.7 (9.9) 51.7 (10.3) 
Mean BMI (SD, kg/m2) 25.4 (4.1) 25.2 (4.1) 25.2 (4.3) 25.9 (4.6) 
Mean total energy (SD, kcal/d) 1924 (609) 2024 (596) 2096 (596) 2257 (628) 
Mean alcohol (SD, g/d) 13.9 (19.9) 12.3 (16.8) 11.3 (15.6) 10.4 (15.6) 
Smoking status (%)a         
  Never 39.1 47.3 53.4 56.1 
  Former 26.9 28.2 26.7 24.9 
  Current 32.6 22.7 17.8 16.4 
Education (%)a         
  Primary 30.4 27 28.3 34.3 
  Secondary 67.9 69.9 67.3 60.8 
Physical activity (%)a         
  Inactive 51 51.3 55 58.4 
  Active 46.1 46.4 43.5 41 
Diabetes at baseline (%)a         
  No 90.9 88.5 87.9 89.5 
  Yes 2.1 2.1 2.1 3.1 
  Unknown 7.2 9.2 9.1 7.1 
Menopausal status (%)a,b         
  Premenopausal 38.3 34.7 33.2 33.9 
  Postmenopausal 39.2 42.7 44.5 45.4 
  Perimenopausal 20.6 20.1 19.3 17 
  Surgical menopause 2 2.6 3 3.8 
Oral contraceptive use (%)a,b         
  No 31.6 35.7 41.4 50.2 
  Yes 63.6 61.6 56.7 48.5 
  Unknown 4.8 2.7 1.9 1.3 
Infertility problems (%)a,b         
  No 44.5 56.5 69.1 79.3 
  Yes 1.5 2.6 3.7 4.3 
  Unknown 54 40.9 27.2 16.4 
Abbreviations: BMI Body Mass Index; Q Quartile; SD Standard Deviation 
aMissing values: Smoking status 9,676 (2.03%), Education 16,929 (3.56%), Physical 
activity 8,824 (1.85%), Oral contraceptive use 8,427 (1.77%), Infertility problems 
111,162 (23.35%), Diabetes at baseline 38,970 (8.19%) 
b% only in women (n=333,876) 
Supplementary table 2. Modelling strategy to estimate hazard ratios and 95% 
confidence intervals for differentiated thyroid cancer according to quartile of 
intake of vegetables, fruits and fruit juices in the EPIC study 
    
Intake 
(g/d) 
Differentiated thyroid carcinoma 
    No of 
cases 
Model A1a Model A2b Model B1c Model B2d Model B33 
    HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) 
Total vegetables and fruits             
  Quartile 1 <250 137 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 
  Quartile 2 250-391 163 0.93 (0.73-1.17) 0.93 (0.73-1.18) 0.93 (0.73-1.18) 0.91 (0.72-1.16) 0.90 (0.71-1.15) 
  Quartile 3 392-576 226 1.03 (0.81-1.30) 1.02 (0.81-1.30) 1.03 (0.81-1.31) 1.00 (0.78-1.27) 0.98 (0.77-1.25) 
  Quartile 4 >576 222 0.93 (0.73-1.20) 0.93 (0.72-1.19) 0.94 (0.73-1.22) 0.89 (0.68-1.15) 0.87 (0.67-1.13) 
  P-trend     0.69 0.64 0.78 0.44 0.38 
  Observed continuous (per 100g/d) 1.01 (0.97-1.04) 1.00 (0.97-1.04) 1.01 (0.98-0.99) 0.99 (0.97-1.03) 1.00 (0.97-1.03) 
  Calibrated continous (per 100g/d) 1.03 (0.96-1.11) 1.03 (0.95-1.11) 1.03 (0.96-1.11) 1.01 (0.94-1.09) 1.09 (0.93-1.09) 
Vegetables               
  Quartile 1 <110 160 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 
  Quartile 2 110-175 164 0.87 (0.69-1.09) 0.87 (0.69-1.09) 0.87 (0.70-1.09) 0.87 (0.69-1.08) 0.87 (0.69-1.09) 
  Quartile 3 176-276 204 0.93 (0.74-1.17) 0.93 (0.74-1.17) 0.94 (0.75-1.19) 0.93 (0.74-1.17) 0.93 (0.73-1.17) 
  Quartile 4 >276 220 0.91 (0.71-1.16) 0.90 (0.70-1.15) 0.92 (0.71-1.18) 0.89 (0.69-1.14) 0.87 (0.67-1.13) 
  P-trend     0.69 0.62 0.77 0.56 0.47 
  Observed continuous (per 100g/d) 0.99 (0.99-1.00) 0.98 (0.93-1.05) 0.99 (0.93-1.06) 0.98 (0.92-1.04) 0.97 (0.91-1.04) 
  Calibrated continous (per 100g/d) 1.02 (0.84-1.24) 1.01 (0.83-1.23) 1.03 (0.84-1.25) 0.99 (0.81-1.21) 0.97 (0.79-1.19) 
Fruits               
  Quartile 1 <106 149 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 
  Quartile 2 106-194 162 0.91 (0.73-1.15) 0.91 (0.72-1.15) 0.92 (0.73-1.15) 0.90 (0.71-1.13) 0.90 (0.71-1.13) 
  Quartile 3 195-314 194 0.90 (0.72-1.13) 0.90 (0.72-1.13) 0.91 (0.73-1.14) 0.88 (0.70-1.10) 0.88 (0.70-1.11) 
  Quartile 4 >314 243 1.04 (0.83-1.31) 1.04 (0.83-1.31) 1.06 (0.84-1.33) 1.00 (0.79-1.26) 1.01 (0.79-1.28) 
  P-trend     0.43 0.43 0.36 0.64 0.59 
  Observed continuous (per 100g/d) 1.02 (0.97-1.06) 1.02 (0.97-1.06) 1.02 (0.98-1.06) 1.00 (0.97-1.05) 1.01 (0.97-1.06) 
  Calibrated continous (per 100g/d) 1.04 (0.95-1.13) 1.04 (0.95-1.13) 1.04 (0.95-1.14) 1.02 (0.93-1.12) 1.02 (0.93-1.12) 
Fruit juices               
  Quartile 1 <1 205 1(Ref) 1 (Ref) 1 (Ref) 1(Ref) 1 (ref) 
  Quartile 2 1-20 151 1.03 (0.82-1.29) 1.03 (0.82-1.30) 1.03 (0.82-1.29) 1.03 (0.82-1.29) 1.03 (0.82-1.30) 
  Quartile 3 21-94 207 1.14 (0.93-1.41) 1.16 (0.94-1.43) 1.15 (0.93-1.42) 1.16 (0.94-1.43) 1.17 (0.95-1.44) 
  Quartile 4 >94 185 1.19 (0.96-1.48) 1.22 (0.98-1.52) 1.21 (0.97-1.50) 1.23 (0.98-1.53) 1.24 (0.99-1.54) 
  P-trend     0.10 0.06 0.08 0.06 0.05 
  Observed continuous (per 100g/d) 1.02 (0.99-1.05) 1.02 (0.99-1.05) 1.02 (0.99-1.06) 1.02 (0.99-1.05) 1.02 (0.99-1.06) 
  Calibrated continous (per 100g/d) 1.04 (0.95-1.14) 0.99 (0.92-1.08) 0.99 (0.92-1.08) 0.99 (0.92-1.08) 0.99 (0.92-1.08) 
Abbreviations: HR Hazard Ratio; CI confidence interval; TC thyroid carcinoma 
aModel A1: Cox model stratified by centre, age at baseline and sex 
bModel A2: Model 1 additionally adjusted for BMI, smoking status, education, physical 
activity, menopausal status and type, oral contraceptive use, infertility problems  
cModel B1 Cox model stratified by centre, age at baseline and sex, and adjusted for total 
energy intake 
dModel B2: Model B1 additionally adjusted for BMI, smoking status, education, 
physical activity, menopause status and type, oral contraceptive use, infertility 
problems, and alcohol intake 
eModel B3: Model B2 additionally adjusted for vegetables, fruits and/or fruit juices, 
accordingly. 
 
Supplementary table 3. Hazard ratios and 95% confidence intervals for overall, papillary and follicular thyroid cancer risk according to 
quartiles of intake of juices in separate analyses by physical activity status and categories of BMI in the EPIC study         Overall differentiated TC     Papillary TC     FollicularTC         No of 
cases 








Model A1a Model B2b P-
value     Intake HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) 
Physically inactive (n=256,627) 
  
                        Quartile 1 <0.3 127 1 (ref) 1 (ref)   104 1 (ref) 1 (ref)   18 1 (ref) 1 (ref)     Quartile 2 0.3-16.4 92 1.05 (0.79-1.41) 1.05 (0.79-1.41)   71 1.01 (0.73-1.41) 1.01 (0.73-1.40)   16 1.23 (0.59-2.55) 1.27 (0.61-2.63)     Quartile 3 16.5-78.6 117 1.17 (0.89-1.53) 1.17 (0.90-1.54)   94 1.16 (0.86-1.57) 1.16 (0.86-1.56)   17 1.30 (0.63-2.67) 1.39 (0.67-2.87)     Quartile 4 >78.6 126 1.30 (0.99-1.71) 1.31 (0.99-1.72)   94 1.24 (0.91-1.68) 1.23 (0.90-1.67)   17 1.02 (0.48-2.18) 1.12 (0.51-2.42)     P-trend     0.05 0.05     0.15 0.17     0.75 0.93   
  Observed continuous (per 50g/d) 1.04 (1.00-1.08) 1.04 (1.00-1.08) 0.19c   1.05 (1.00-1.09) 1.04 (1.00-1.09) 0.20c   0.98 (0.87-1.10) 0.98 (0.87-1.10) 0.15c 
  Calibrated continuous (per 50g/d) 1.03 (0.94-1.14) 1.03 (0.94-1.13) 0.20c   1.06 (0.95-1.18) 1.06 (0.95-1.18) 0.14c   0.95 (0.76-1.20) 0.95 (0.76-1.19) 0.58c 
Physically active (n=210,657)                           Quartile 1 <1.7 75 1 (ref) 1 (ref)   64 1 (ref) 1 (ref)   7 1 (ref) 1 (ref)     Quartile 2 1.7-28.6 66 0.98 (0.69-1.40) 0.98 (0.69-1.40)   57 1.00 (0.68-1.47) 0.99 (0.67-1.48)   9 1.45 (0.51-4.08) 1.52 (0.54-4.32)     Quartile 3 28.7-100.1 76 1.07 (0.77-1.50) 1.08 (0.77-1.51)   63 1.04 (0.72-1.50) 0.78 (0.50-1.20)   10 1.58 (0.58-4.28) 1.64 (0.60-4.48)     Quartile 4 >100.1 65 0.97 (0.69-1.39) 1.00 (0.70-1.42)   51 0.90 (0.61-1.32) 0.69 (0.45-1.08)   14 2.39 (0.91-6.28) 2.63 (0.98-7.02)     P-trend     0.91 0.99     0.54 0.63     0.08 0.06   
  Observed continuous (per 50g/d) 0.99 (0.94-1.05) 1.00 (0.94-1.06)     0.98 (0.91-1.05) 0.98 (0.91-1.05)     1.05 (0.96-1.15) 1.07 (0.97-1.19)   
  Calibrated continuous (per 50g/d) 0.93 (0.80-1.08) 0.93 (0.80-1.08)     0.92 (0.77-1.10) 0.92 (0.77-1.09)     1.01 (0.80-1.27) 1.03 (0.81-1.31)   
BMI<25 (n=246,028)                           Quartile 1 <1.2 108 1(ref) 1(ref)   93 1(ref) 1(ref)   8 1(ref) 1(ref)     Quartile 2 1.2-27.6 78 0.92 (0.68-1.25) 0.93 (0.68-1.26)   63 0.86 (0.61-1.20) 0.87 (0.62-1.21)   14 1.98 (0.80-4.87) 1.95 (0.79-4.80)     Quartile 3 27.7-100.1 95 1.11 (0.84-1.48) 1.13 (0.85-1.51)   81 1.11 (0.82-1.52) 1.14 (0.83-1.55)   11 1.48 (0.58-3.77) 1.46 (0.57-3.73)     Quartile 4 >100.1 115 1.39 (1.05-1.84) 1.43 (1.08-1.89)   89 1.29 (0.95-1.76) 1.33 (0.98-1.82)   20 2.61 (1.09-6.23) 2.64 (1.09-6.38)   
  P-trend     0.004 0.002     0.02 0.02     0.06 0.06   
  Observed continuous (per 50g/d) 1.04 (1.00-1.09) 1.05 (1.00-1.09) 0.05d   1.04 (1.00-1.08) 1.05 (1.00-1.10) 0.05d   1.05 (0.95-1.15) 1.04 (0.95-1.15) 0.20d 
  Calibrated continuous (per 50g/d) 1.00 (0.88-1.13) 1.00 (0.88-1.13) 0.87d   0.99 (0.85-1.15) 0.99 (0.85-1.16) 0.78d   1.05 (0.85-1.30) 1.04 (0.84-1.29) 0.46d 
BMI≥25 (n=230,079)                           Quartile 1 <0.57 98 1(ref) 1(ref)   79 1(ref) 1(ref)   17 1(ref) 1(ref)     Quartile 2 0.57-15.8 76 1.09 (0.78-1.52) 1.09 (0.78-1.52)   58 1.05 (0.72-1.54) 1.05 (0.72-1.54)   14 1.20 (0.55-2.61) 1.23 (0.56-2.68)     Quartile 3 15.9-75.91 97 1.25 (0.91-1.71) 1.26 (0.91-1.73)   77 1.22 (0.86-1.74) 1.21 (0.85-1.73)   12 1.16 (0.52-2.61) 1.26 (0.56-2.86)     Quartile 4 >75.91 81 1.04 (0.75-1.46) 1.06 (0.75-1.48)   61 0.98 (0.67-1.43) 0.96 (0.66-1.41)   13 0.98 (0.42-2.25) 1.10 (0.48-2.56)     P-trend     0.93 0.99     0.71 0.64     0.76 0.98   
  Observed continuous (per 50g/d) 0.99 (0.94-1.05) 0.99 (0.94-1.05)     0.99 (0.94-1.06) 0.99 (0.93-1.05)     0.98 (0.85-1.12) 0.99 (0.87-1.14)   
  Calibrated continuous (per 50g/d) 0.99 (0.90-1.10) 0.99 (0.89-1.10)     1.02 (0.91-1.14) 1.01 (0.90-1.13)     0.91 (0.69-1.20) 0.93 (0.71-1.22)   
Abbreviations: BMI Body mass Index; HR Hazard Ratio; CI confidence interval; TC thyroid carcinoma 
aModel A1: Cox model stratified by centre, age at baseline and sex 
bModel B2: Cox model stratified by centre, age at baseline and sex, and adjusted for BMI, smoking status, education level, physical activity, total 
energy and alcohol intake. In women, also adjusted for menopausal status and type, oral contraceptive use, and infertility problems. 
cp-heterogeneity for physically inactive vs. physically active using the Wald test 
dp-heterogeneity for participants with a BMI<25 vs. participants with a BMI≥25 using the Wald test 
 
 
Table 1. Distribution of participants, thyroid cancer cases according to cancer type and intakes of vegetables, fruits and fruit juices by 
sex across the EPIC countries 
Country All Person-years 
Differentiated thyroid carcinoma cases Total vegetables and fruits (g/d) Vegetables (g/d) Fruits (g/d) Fruit juices (g/d) 
Overall  Papillary Follicular NOS Median (25th-75th) Median (25th-75th) Median (25th-75th) Median (25th-75th) 
WOMEN                     
France 67,391 869,292 248 227 19 2 510 (379-669) 264 (189-356) 234 (145-332) 18 (0-83) 
Italy 30,511 434,977 106 81 16 9 483 (353-638) 162 (109-232) 306 (210-426) 8 (0-38) 
Spain 24,846 398,818 74 62 11 1 523 (363-714) 216 (138-315) 279 (169-429) 1 (0-6) 
United Kingdom 52,565 793,526 39 24 10 5 496 (359-671) 256 (186-347) 223 (138-338) 51 (9-120) 
The Netherlands 26,910 384,225 13 10 3 0 325 (232-432) 126 (98-162) 187 (119-278) 56 (13-137) 
Greece 15,229 168,454 28 22 1 5 753 (586-945) 412 (317-527) 332 (233-443) 24 (6-47) 
Germany 27,373 284,894 67 47 18 2 254 (189-344) 117 (89-156) 118 (88-198) 114 (38-248) 
Sweden 26,365 442,218 29 20 4 5 310 (206-434) 119 (70-184) 175 (109-265) 16 (0-89) 
Denmark 28,714 432,361 26 18 8 0 358 (244-504) 172 (112-244) 170 (98-274) 9 (2-43) 
Norway 33,972 452,152 36 31 4 1 268 (185-378) 126 (87-179) 130 (72-212) 43 (0-107) 
TOTAL 333,876 4,660,917 666 542 94 30 415 (274-594) 186 (118-286) 210 (120-324) 21 (1-95) 
MEN                     
Italy 14,032 195,955 21 16 3 2 460 (332-620) 147 (99-211) 296 (195-423) 13 (0-38) 
Spain 15,138 239,107 6 4 2 0 540 (361-751) 240 (150-353) 272 (145-435) 1 (0-5) 
United Kingdom 22,850 329,232 5 5 0 0 411 (291-564) 223 (159-306) 172 (100-270) 17 (8-120) 
The Netherlands 9,627 140,422 4 2 1 1 247 (176-348) 115 (88-148) 125 (66-224) 40 (7-108) 
Greece 10,815 112,787 8 6 0 2 798 (631-992) 451 (356-565) 334 (233-450) 26 (7-61) 
Germany 21,178 219,542 15 11 3 1 216 (160-293) 108 (81-142) 98 (65-160) 101 (32-224) 
Sweden 22,301 358,848 10 5 3 2 214 (128-332) 82 (40-142) 119 (60,6-198) 13 (0-71) 
Denmark 26,291 382,654 13 10 3 1 281 (185-402) 151 (97-216) 115 (54-192) 8 (2-43) 
TOTAL 228,875 1,978,547 82 59 15 8 328 (203-523) 151 (94-248) 156 (82-280) 17 (1-77) 
ALL 476,108 6,639,464 748 601 109 38 391  (250-576) 175 (110-276) 194 (106-314) 20(1-94) 
Abbreviations: NOS not otherwise specified 
Table 1. Hazard ratios and 95% confidence intervals for overall, papillary and follicular thyroid cancer according to quartile of intake 
of vegetables, fruits and fruit juices in the EPIC study 
    
Intake 
(g/d) 
 Overall differentiated TC  Papillary TC  Follicular TC P-valuec 
    No of 
cases 
Model A1a Model B2b No of 
cases 
Model A1a Model B2b No of 
cases 
Model A1a Model B2b  
    HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)  
Total vegetables and fruits           
  Quartile 1 <250 137 1 (ref) 1 (ref) 100 1 (ref) 1 (ref) 29 1 (ref) 1 (ref)  
  Quartile 2 250-391 163 0.93 (0.73-1.17) 0.91 (0.72-1.16) 131 1.00 (0.76-1.31) 0.98 (0.74-1.28) 22 0.66 (0.37-1.17) 0.67 (0.38-1.20)  
  Quartile 3 392-576 226 1.03 (0.81-1.30) 1.00 (0.78-1.27) 190 1.11 (0.85-1.45) 1.06 (0.81-1.40) 31 0.92 (0.52-1.62) 0.96 (0.54-1.71)  
  Quartile 4 >576 222 0.93 (0.73-1.20) 0.89 (0.68-1.15) 180 0.98 (0.85-1.45) 0.91 (0.68-1.22) 27 0.83 (0.45-1.56) 0.84 (0.43-1.62)  
  P-trend   0.69 0.44  0.77 0.43  0.87 0.90  
  Observed continuous (per 100g/d) 1.01 (0.97-1.04) 0.99 (0.97-1.03)  1.00 (0.97-1.04) 1.00 (0.96-1.03)  1.05 (0.96-1.13) 1.05 (0.97-1.15) 0.86 
  Calibrated continuous (per 100g/d) 1.03 (0.96-1.11) 1.01 (0.94-1.09)  1.02 (0.94-1.11) 1.00 (0.91-1.09)  1.15 (0.96-1.37) 1.15 (0.95-1.39) 0.20 
Vegetables            
  Quartile 1 <110 160 1 (ref) 1 (ref) 122 1 (ref) 1 (ref) 26 1 (ref) 1 (ref)  
  Quartile 2 110-175 164 0.87 (0.69-1.09) 0.87 (0.69-1.08) 124 0.84 (0.65-1.09) 0.83 (0.64-1.08) 28 1.01 (0.58-1.75) 1.05 (0.60-1.83)  
  Quartile 3 176-276 204 0.93 (0.74-1.17) 0.93 (0.74-1.17) 169 0.94 (0.73-1.22) 0.92 (0.71-1.20) 32 1.24 (0.71-2.19) 1.34 (0.75-2.39)  
  Quartile 4 >276 220 0.91 (0.71-1.16) 0.89 (0.69-1.14) 186 0.92 (0.70-1.21) 0.88 (0.66-1.17) 23 1.04 (0.54-2.00) 1.12 (0.57-2.22)  
  P-trend   0.69 0.56  0.89 0.66  0.87 0.71  
  Observed continuous (per 100g/d) 0.99 (0.99-1.00) 0.98 (0.92-1.04)  0.99 (0.92-1.05) 0.97 (0.91-1.04)  1.07 (0.91-1.26) 1.09 (0.92-1.29) 0.83 
  Calibrated continuous (per 100g/d) 1.02 (0.84-1.24) 0.99 (0.81-1.21)  1.00 (0.80-1.25) 0.96 (0.77-1.20)  1.31 (0.81-2.10) 1.34 (0.94-2.16) 0.13 
Fruits             
  Quartile 1 <106 149 1 (ref) 1 (ref) 114 1 (ref) 1 (ref) 28 1 (ref) 1 (ref)  
  Quartile 2 106-194 162 0.91 (0.73-1.15) 0.90 (0.71-1.13) 133 0.97 (0.75-1.25) 0.95 (0.73-1.22) 23 0.74 (0.42-1.31) 0.74 (0.42-1.30)  
  Quartile 3 195-314 194 0.90 (0.72-1.13) 0.88 (0.70-1.10) 157 0.94 (0.73-1.22) 0.91 (0.70-1.17) 24 0.69 (0.39-1.23) 0.70 (0.39-1.25)  
  Quartile 4 >314 243 1.04 (0.83-1.31) 1.00 (0.79-1.26) 197 1.08 (0.84-1.39) 1.02 (0.79-1.33) 34 1.01 (0.58-1.78) 0.99 (0.55-1.78)  
  P-trend   0.43 0.64  0.41 0.68  0.70 0.73  
  Observed continuous (per 100g/d) 1.02 (0.97-1.06) 1.00 (0.97-1.05)  1.02 (0.97-1.06) 1.01 (0.96-1.05)  1.05 (0.94-1.17) 1.05 (0.94-1.18) 0.88 
  Calibrated continuous (per 100g/d) 1.04 (0.95-1.13) 1.02 (0.93-1.12)  1.03 (0.93-1.13) 1.00 (0.91-1.11)  1.15 (0.92-1.42) 1.15 (0.91-1.43) 0.28 
Fruit juices            
  Quartile 1 <1 205 1(Ref) 1(Ref) 172 1 (Ref) 1 (Ref) 24 1 (Ref) 1 (Ref)  
  Quartile 2 1-20 151 1.03 (0.82-1.29) 1.03 (0.82-1.29) 121 1.38 (0.75-2.54) 1.40 (0.76-2.57) 25 1.01 (0.78-1.30) 1.00 (0.78-1.30)  
  Quartile 3 21-94 207 1.14 (0.93-1.41) 1.16 (0.94-1.43) 168 1.53 (0.85-2.74) 1.59 (0.88-2.86) 29 1.10 (0.88-1.39) 1.11 (0.88-1.40)  
  Quartile 4 >94 185 1.19 (0.96-1.48) 1.23 (0.98-1.53) 140 1.57 (0.87-2.85) 1.69 (0.92-3.08) 31 1.10 (0.87-1.41) 1.12 (0.88-1.43)  
  P-trend   0.10 0.06  0.28 0.19  0.41 0.35  
  Observed continuous (per 50g/d) 1.02 (0.99-1.05) 1.02 (0.99-1.06)  1.02 (0.94-1.10) 1.02 (0.94-1.11)  1.02 (0.98-1.06) 1.02 (0.98-1.06) 0.37 
 Calibrated continuous (per 50g/d) 1.04 (0.95-1.14) 0.99 (0.92-1.08)  1.01 (0.92-1.10) 1.01 (0.92-1.10)  0.98 (0.82-1.16) 0.98 (0.82-1.16) 0.65 
Abbreviations: HR Hazard Ratio; CI confidence interval; TC thyroid carcinoma 
aModel A1: Cox model stratified by centre, age at baseline and sex,  
bModel B2: Model A1 additionally adjusted for body mass index, smoking status, education level, physical activity, total energy and alcohol 
intake. In women, also adjusted for menopausal status and type, oral contraceptive use, and infertility problems. 
cP for heterogeneity using the Wald test. 
 
Table 1. Hazard ratios and 95% confidence intervals for overall, papillary and follicular thyroid cancer according to continuous variable 
of intake of subgroups of vegetables and fruits in the EPIC study 






  Observedb Calibratedc Observedb Calibratedc Observedb Calibratedc 
Observed Calibrated 
  HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) 
Vegetables                 
Leafy vegetables (per 50g/d)a 0.98 (0.88-1.09) 1.01 (0.69-1.47) 0.96 (0.85-1.08) 0.94 (0.62-1.43) 1.15 (0.86-1.53) 1.56 (0.56-4.34) 0.25 0.34 
Fruiting vegetables (per 50g/d) 1.02 (0.96-1.09) 1.00 (0.84-1.20) 1.03 (0.96-1.10) 1.01 (0.83-1.24) 1.06 (0.89-1.27) 1.13 (0.72-1.79) 0.27 0.55 
Root vegetables (per 50g/d) 1.04 (0.90-1.18) 1.16 (0.84-1.58) 1.06 (0.91-1.23) 1.24 (0.88-1.74) 1.04 (0.73-1.47) 1.11 (0.52-2.37) 0.62 0.7 
Cabbages (per 50g/d) 1.02 (0.88-1.19) 1.17 (0.70-1.96) 1.09 (0.92-1.28) 1.34 (0.75-2.40) 0.81 (0.51-1.28) 0.99 (0.28-3.57) 0.64 0.52 
Mushrooms (per 10g/d) 1.03 (0.93-1.14) 1.02 (0.67-1.56) 1.06 (0.95-1.17) 1.03 (0.63-1.68) 0.78 (0.53-1.14) 0.82 (0.25-2.67) 0.24 0.45 
Grain and pod vegetables (per 10g/d) 1.02 (0.95-1.09) 1.04 (0.80-1.36) 1.04 (0.97-1.12) 1.15 (0.86-1.53) 1.04 (0.86-1.24) 0.83 (0.40-1.74) 0.3 0.22 
Onion/garlic (per 10g/d) 1.00 (0.93-1.09) 0.97 (0.78-1.21) 1.01 (0.92-1.11) 0.97 (0.76-1.25) 1.02 (0.84-1.23) 0.97 (0.55-1.72) 0.49 1.00 
Sprouts/stalk vegetables (per 10g/d) 0.96 (0.90-1.03) 0.91 (0.75-1.09) 1.00 (0.93-1.07) 1.01 (0.82-1.24) 0.72 (0.56-0.94)e 0.56 (0.34-0.91)e 0.03 <0.001 
Fruits                 
Citrus fruits (per 50g/d) 0.98 (0.92-1.05) 1.02 (0.89-1.15) 0.97 (0.91-1.05) 1.00 (0.87-1.15) 1.11 (0.96-1.29) 1.26 (0.95-1.68) 0.54 0.17 
Apples and pears (per 50g/d) 0.98 (0.93-1.03) 0.96 (0.89-1.04) 0.98 (0.92-1.04) 0.96 (0.88-1.05) 0.97 (0.85-1.11) 0.92 (0.76-1.12) 0.51 0.6 
Berries (per 50g/d) 1.03 (0.87-1.21) 1.07 (0.81-1.41) 1.08 (0.91-1.29) 1.17 (0.87-1.58) 0.86 (0.52-1.42) 0.72 (0.30-1.74) 0.15 0.05 
Stone fruits (per 50g/d) 1.04 (0.96-1.12) 1.10 (0.90-1.33) 1.01 (0.93-1.11) 1.05 (0.85-1.30) 1.25 (0.80-1.04) 1.40 (0.84-2.33) 0.81 0.34 
Banana (per 50g/d) 0.94 (0.81-1.09) 0.82 (0.59-1.13) 0.97 (0.82-1.14) 0.91 (0.63-1.31) 0.90 (0.61-1.30) 0.64 (0.29-1.40) 0.73 0.12 
Other fruits (per 50g/d) 1.06 (0.96-1.17) 1.05 (0.80-1.36) 1.07 (0.96-1.19) 1.11 (0.83-1.47) 0.98 (0.69-1.40) 0.74 (0.31-1.75) 0.18 0.10 
Abbreviations: HR Hazard Ratio; CI confidence interval; TC thyroid carcinoma 
aexcluding Norway (n=33 972 participants) 
bModel B2: Cox model stratified by centre, age at baseline and sex, and adjusted for body mass index, smoking status, education level, physical 
activity, total energy and alcohol intake. In women, also adjusted for menopausal status and type, oral contraceptive use, and infertility problems. 
cModel B2 applied to calibrated variables 
dP for heterogeneity using the Wald test. 
eAfter applying the Bonferroni correction, the inverse association was no longer statistically significant.   
